Metabolic syndrome: A review of emerging markers and management

被引:17
|
作者
Singh, B. [1 ]
Arora, S. [1 ]
Goswami, B. [1 ]
Mallika, V. [1 ]
机构
[1] GB Pant Hosp, Dept Biochem, New Delhi, India
关键词
Insulin resistance; Dyslipidemia; Cytokines; Adipokines; Inflammation;
D O I
10.1016/j.dsx.2009.04.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Metabolic syndrome is a cluster of metabolic abnormalities and related clinical syndromes most important of which are coronary artery disease and type 2 diabetes mellitus. Insulin resistance along with visceral adiposity, dyslipidemia and chronic subclinical proinflammatory state are the main characteristic features of metabolic syndrome. Insulin resistance is not a disease, but a description of a physiologic state, and approximately one third of an apparently healthy population is sufficiently insulin resistant to be at increased risk. Our understanding of metabolic syndrome has improved tremendously over the years, but certain aspects of its pathogenesis still remain elusive to the scientific world. Further research and application of the knowledge can help in better management of type 2 diabetes mellitus and coronary artery disease, direct fallout of metabolic syndrome. In-depth knowledge of the markers of metabolic syndrome will help in better understanding of the condition. (C) 2009 Diabetes India. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:240 / 254
页数:15
相关论文
共 50 条
  • [1] An update on metabolic syndrome: Metabolic risk markers and adipokines in the development of metabolic syndrome
    Kumari, Reena
    Kumar, Sandeep
    Kant, Ravi
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (04) : 2409 - 2417
  • [2] Metabolic syndrome management
    Stone, Neil J.
    Schmeltz, Lowell R.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (13) : 2059 - 2075
  • [3] Dyslipidemia Management for Elderly People with Metabolic Syndrome: A Mini-Review
    Chen, Chun-Yen
    Lee, Chun-Wei
    Chien, Shih-Chieh
    Su, Min-I.
    Lin, Shu-I.
    Cheng, Chung-Wei
    Hung, Ta-Chuan
    Yeh, Hung-I.
    INTERNATIONAL JOURNAL OF GERONTOLOGY, 2018, 12 (01) : 7 - 11
  • [4] Biological markers, lifestyle factors, and metabolic syndrome
    Kawada, Tomoyuki
    Wakayama, Yoko
    Watanabe, Ryoji
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (03): : 454 - 455
  • [5] Metabolic Syndrome and Oral Markers of Cardiometabolic Risk
    Tremblay, Monique
    Gaudet, Daniel
    Brisson, Diane
    JOURNAL OF THE CANADIAN DENTAL ASSOCIATION, 2011, 77 : 1 - 7
  • [6] Inflammatory markers and cardiovascular risk in the metabolic syndrome
    Espinola-Klein, Christine
    Gori, Tommaso
    Blankenberg, Stefan
    Munzel, Thomas
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2011, 16 : 1663 - 1674
  • [7] Systematic review of the effect of caffeine therapy effect on cardiometabolic markers in rat models of the metabolic syndrome
    Isa Abdulla Alhadi
    Ahmed Mohammed Al Ansari
    Aseel Fuad Fahad AlSaleh
    Ahmed M. Abdulla Alabbasi
    BMC Endocrine Disorders, 23
  • [8] Systematic review of the effect of caffeine therapy effect on cardiometabolic markers in rat models of the metabolic syndrome
    Alhadi, Isa Abdulla
    Al Ansari, Ahmed Mohammed
    AlSaleh, Aseel Fuad Fahad
    Alabbasi, Ahmed M. Abdulla
    BMC ENDOCRINE DISORDERS, 2023, 23 (01)
  • [9] Relationship Between Several Markers and Presence of Metabolic Syndrome or Components of the Metabolic Syndrome in Japanese Workers
    Kawada, Tomoyuki
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2012, 54 (08) : 984 - 988
  • [10] Anthocyanins in the Management of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review
    Naseri, Rozita
    Farzaei, Fatemeh
    Haratipour, Pouya
    Nabavi, Seyed Fazel
    Habtemariam, Solomon
    Farzaei, Mohammad Hosein
    Khodarahmi, Reza
    Tewari, Devesh
    Momtaz, Saeideh
    FRONTIERS IN PHARMACOLOGY, 2018, 9